Regulation Same-Day Injectable Buprenorphine at Kaiser Permanente Napa-Solano Runs on Pharmacy Stock and Open Schedules. Its Three-Day Dosing Sequence Departs From the Label. Addressing systemic retail prescription abandonment that sees over a third of initial buprenorphine scripts left unfilled, Kaiser Permanente Napa-Solano’s Addiction Medicine and Recovery Services ha... Read More Featured Healthcare Articles Regulation Pediatric Feeding Disorder Reaches as Many as 1 in 23 Young Children a Year, and ABA and Eating Disorder Programs Are Both Building for It Read More Regulation New York Early Intervention Telehealth Rate Cuts Annulled by Albany Judge. CMS Had Approved the Same 22 and 10 Percent Reductions in April. Read More Regulation Tobacco Use Disorder Kills More Former Addiction Patients Than Alcohol, Yet Most Treatment Programs Still Skip the Medication Read More Regulation New Jersey DDD Behavioral Supports Licensure Deadline Is May 6, 2027. BACB Certification Alone Will No Longer Qualify Clinicians to Do the Work. Read More Get the Latest Behavioral Health News and Articles Direct to Your Inbox Email Subscribe Latest Articles Technology AI ROI in Healthcare Billing Comes From Rebuilding the Process, Camber CEO Christophe Rimann Says. Apollo Sees No AI Payoff Outside Tech, and He Agrees. Read More Regulation VA Community Care Spent $1.9 Billion on Residential Substance Use Treatment in Four Years, 43 Percent of Behavioral Health Referral Dollars Read More Technology Neurora FDA Clearance Brings AI Biometrics to Autism Diagnosis. CentralReach’s Dr. Thomas Frazier Says Clinician Confidence Could Shorten Wait Lists. Read More Regulation Low-Barrier Buprenorphine at Kaiser Napa-Solano Dropped Treatment, Group, and Abstinence Requirements. Its Recovery Group Ended Once Attendance Became Optional. Read More Technology AI ROI in Healthcare Billing Comes From Rebuilding the Process, Camber CEO Christophe Rimann Says. Apollo Sees No AI Payoff Outside Tech, and He Agrees. Read More Regulation VA Community Care Spent $1.9 Billion on Residential Substance Use Treatment in Four Years, 43 Percent of Behavioral Health Referral Dollars Read More Technology Neurora FDA Clearance Brings AI Biometrics to Autism Diagnosis. CentralReach’s Dr. Thomas Frazier Says Clinician Confidence Could Shorten Wait Lists. Read More Regulation Low-Barrier Buprenorphine at Kaiser Napa-Solano Dropped Treatment, Group, and Abstinence Requirements. Its Recovery Group Ended Once Attendance Became Optional. Read More Article Categories M&A Technology Regulation
Regulation Same-Day Injectable Buprenorphine at Kaiser Permanente Napa-Solano Runs on Pharmacy Stock and Open Schedules. Its Three-Day Dosing Sequence Departs From the Label. Addressing systemic retail prescription abandonment that sees over a third of initial buprenorphine scripts left unfilled, Kaiser Permanente Napa-Solano’s Addiction Medicine and Recovery Services ha... Read More
Regulation Pediatric Feeding Disorder Reaches as Many as 1 in 23 Young Children a Year, and ABA and Eating Disorder Programs Are Both Building for It Read More
Regulation New York Early Intervention Telehealth Rate Cuts Annulled by Albany Judge. CMS Had Approved the Same 22 and 10 Percent Reductions in April. Read More
Regulation Tobacco Use Disorder Kills More Former Addiction Patients Than Alcohol, Yet Most Treatment Programs Still Skip the Medication Read More
Regulation New Jersey DDD Behavioral Supports Licensure Deadline Is May 6, 2027. BACB Certification Alone Will No Longer Qualify Clinicians to Do the Work. Read More
Technology AI ROI in Healthcare Billing Comes From Rebuilding the Process, Camber CEO Christophe Rimann Says. Apollo Sees No AI Payoff Outside Tech, and He Agrees. Read More
Regulation VA Community Care Spent $1.9 Billion on Residential Substance Use Treatment in Four Years, 43 Percent of Behavioral Health Referral Dollars Read More
Technology Neurora FDA Clearance Brings AI Biometrics to Autism Diagnosis. CentralReach’s Dr. Thomas Frazier Says Clinician Confidence Could Shorten Wait Lists. Read More
Regulation Low-Barrier Buprenorphine at Kaiser Napa-Solano Dropped Treatment, Group, and Abstinence Requirements. Its Recovery Group Ended Once Attendance Became Optional. Read More
Technology AI ROI in Healthcare Billing Comes From Rebuilding the Process, Camber CEO Christophe Rimann Says. Apollo Sees No AI Payoff Outside Tech, and He Agrees. Read More
Regulation VA Community Care Spent $1.9 Billion on Residential Substance Use Treatment in Four Years, 43 Percent of Behavioral Health Referral Dollars Read More
Technology Neurora FDA Clearance Brings AI Biometrics to Autism Diagnosis. CentralReach’s Dr. Thomas Frazier Says Clinician Confidence Could Shorten Wait Lists. Read More
Regulation Low-Barrier Buprenorphine at Kaiser Napa-Solano Dropped Treatment, Group, and Abstinence Requirements. Its Recovery Group Ended Once Attendance Became Optional. Read More